Measuring Bone Remodeling and Recreating the Tumor-Bone Microenvironment Using Calvaria Co-culture and Histomorphometry

Summary

The ex vivo culture of bone explants can be a valuable tool for the study of bone physiology and the potential evaluation of drugs in bone remodeling and bone diseases. The presented protocol describes the preparation and culture of calvarias isolated from newborn mice skulls, as well as its applications.

Abstract

Bone is a connective tissue constituted of osteoblasts, osteocytes, and osteoclasts and a mineralized extracellular matrix, which gives it its strength and flexibility and allows it to fulfill its functions. Bone is continuously exposed to a variety of stimuli, which in pathological conditions can deregulate bone remodeling. To study bone biology and diseases and evaluate potential therapeutic agents, it has been necessary to develop in vitro and in vivo models.

This manuscript describes the dissection process and culture conditions of calvarias isolated from neonatal mice to study bone formation and the bone tumor microenvironment. In contrast to in vitro and in vivo models, this ex vivo model allows preservation of the three-dimensional environment of the tissue as well as the cellular diversity of the bone while culturing under defined conditions to simulate the desired microenvironment. Therefore, it is possible to investigate bone remodeling and its mechanisms, as well as the interactions with other cell types, such as the interactions between cancer cells and bone.

The assays reported here use calvarias from 5-7 day old BALB/C mice. The hemi-calvarias obtained are cultured in the presence of insulin, breast cancer cells (MDA-MB-231), or conditioned medium from breast cancer cell cultures. After analysis, it was established that insulin induced new bone formation, while cancer cells and their conditioned medium induced bone resorption. The calvarial model has been successfully used in basic and applied research to study bone development and cancer-induced bone diseases. Overall, it is an excellent option for an easy, informative, and low-cost assay.

Introduction

Bone is a dynamic connective tissue that has several functions, including supporting the muscles, protecting the internal organs and bone marrow, and storing and releasing calcium and growth factors^1,2. To maintain its integrity and proper function, bone tissue is continuously under the process of remodeling. In general terms, a cycle of bone remodeling can be divided into bone resorption and bone formation¹. An imbalance between these two phases of bone remodeling can lead to the development of bone pathologies. Also, diseases such as breast cancer often affect bone integrity; approximately more than 70% of patients in advanced stages have or will have bone metastases. When breast cancer cells enter the bones, they affect bone metabolism, resulting in excessive resorption (osteoclastic lesions) and/or formation (osteoblastic lesions)³.

To understand the biology of bone diseases and develop new treatments, it is necessary to understand the mechanisms involved in bone remodeling. In cancer research, it is essential to investigate the bone metastasis process and its relation to the metastatic microenvironment. In 1889, Stephen Paget hypothesized that metastases occur when there is compatibility between the tumor cells and the target tissue, and suggested that the metastatic site depends on the affinity of the tumor for the microenvironment⁴. In 1997, Mundy and Guise introduced the concept of the "vicious cycle of bone metastases" to explain how tumor cells modify the bone microenvironment to achieve their survival and growth, and how the bone microenvironment promotes their growth by providing calcium and growth factors^5,6,7.

To characterize the mechanisms involved in bone remodeling and bone metastasis and to evaluate molecules with possible therapeutic potential, it has been necessary to develop in vitro and in vivo models. However, these models currently present many limitations, such as the simplified representation of the bone microenvironment, and their cost^8,9. The culture of bone explants ex vivo has the advantage of maintaining the three-dimensional organization as well as the diversity of bone cells. In addition, experimental conditions can be controlled. The explant models include the culture of metatarsal bones, femoral heads, calvarias, and mandibular or trabecular cores¹⁰. The advantages of the ex vivo models have been demonstrated in diverse studies. In 2009, Nordstrand and collaborators reported the establishment of a coculture model based on the interactions between bone and prostate cancer cells¹¹. Also, in 2012, Curtin and collaborators reported the development of a three-dimensional model using ex vivo cocultures¹². The purpose of such ex vivo models is to recreate the conditions of the bone microenvironment as accurately as possible to be able to characterize the mechanisms involved in normal or pathological bone remodeling and evaluate the efficacy of new therapeutic agents.

The present protocol is based on the procedures published by Garrett¹³ and Mohammad et al.¹⁴. Neonatal mouse calvaria cultures have been used as an experimental model, as they retain the three-dimensional architecture of the bone under development and bone cells, including cells at all stages of differentiation (i.e., osteoblasts, osteoclasts, osteocytes, stromal cells) that lead to mature osteoclasts and osteoblasts, as well as the mineralized matrix¹⁴. The ex vivo model does not represent the pathological process of bone diseases totally. However, effects on bone remodeling or cancer-induced bone osteolysis can be accurately measured.

Briefly, this protocol consists of the following steps: the dissection of calvarias from 5-7 day old mice, calvaria preculture, calvaria culture applications (e.g., culture in the presence of insulin, cancer cells or conditioned medium, and even agents with therapeutic potential, according to the aim of the investigation), bone fixation and calvaria decalcification, tissue processing, histological analysis, and result interpretation.

Protocol

All mice used in these assays were obtained from BALB/c mice strains, using male and female mice indiscriminately. Previous culture experiments have also been performed using other strains, such as FVB, Swiss mice, CD-1, and CsA mice^11,12,14. All mice were housed according to National Institutes of Health (NIH) guidelines, Appendix Q. Procedures involving animal subjects have been approved by the Institutional Animals Care and Use Committee (IACUC) at the Center for Scientific Research and Higher Education at Ensenada (CICESE).

1. Calvarial dissection

1. Sterilize dissection instruments (e.g., 1 x 2 teeth tissue forceps, straight surgical scissors, dissecting scissors, fine-tipped tweezers, fine curved tip dissecting forceps, dissecting forceps, scalpel). Sterile distilled water can be used to clean the surgical tools between each dissection, and sterile 1x PBS can be used for cleaning each hemi-calvaria.
2. Place the sterile dissection instruments, water, 1x PBS, and required materials to carry out the procedure (e.g., micropipettes, precipitate glasses, sterile Petri dishes) in a laminar flow hood.
   NOTE: Carry out the entire procedure under sterile conditions.
3. Add 12 mL of sterile 1x PBS into two 10 cm Petri dishes.
4. Select the pups and place them near the hood.
   NOTE: Dissect the calvarias from 5-7 day old pups.
5. Pick and hold the mouse carefully using dissecting forceps.
6. Decapitate the mouse using dissecting scissors and place the head in a Petri dish with PBS.
   NOTE: Decapitation is not suitable for older mice. If the experiment must be done with older mice, the method of euthanasia should be modified according to the animal experimentation rules.
7. Hold the head firmly by the nose area with 1 x 2 teeth tissue forceps and remove the skin over the skull until the calvaria is visible.
8. Identify the sutures (i.e., sagittal, coronal, and lambdoid) of the skull on the exposed calvaria.
9. Penetrate with the tip of the microscissors approximately 2 mm behind the lambdoid suture and make a straight cut alongside it.
10. Insert the tip of the microscissors on the rear side of the skull. Make a straight cut along the distal side of the lambdoid suture towards the coronal suture. Proceed similarly with the other lambdoid suture.
11. Make another cut (at a 45° angle) to connect the end of the cut made with the cut of the anterior fontanel.
12. Repeat steps 1.10 and 1.11 with the other lambdoid suture.
    NOTE: It is important to identify the sutures to make appropriate cuts and to be able to perform adequate embedding and data analysis.
13. Use fine-tip forceps to remove the calvaria and place it in a Petri dish. With a scalpel, make a straight cut from the posterior fontanel along the sagittal suture through the coronal suture and ending in the anterior fontanel to obtain two hemi-calvarias.
14. Pick up each of the hemi-calvarias with the fine-tipped tweezers and place them in a new Petri dish containing PBS.

2. Calvaria culture

1. Add 1 mL of high-glucose DMEM medium supplemented with 0.1% bovine serum albumin (BSA) and 1% antibiotic/antimycotic (i.e., penicillin and streptomycin) in the wells of a 24 well plate. With fine-tip forceps, pick up each hemi-calvaria and place it in a well.
   NOTE: Put the hemi-calvarias concave side down.
2. Incubate the hemi-calvarias for 24 h at 37 °C with 5% CO₂.
3. Remove the culture medium from each well and add 1 mL of fresh media containing the compound to test or conditioned media from other cells.
   NOTE: Use at least three hemi-calvarias for each treatment group and use negative and positive controls.
4. Incubate the hemi-calvarias for 7 days, changing the media every 2-3 days.

3. Culture with cancer cells

1. Select a Petri dish with cancer cells at 80-90% confluence and trypsinize them. To trypsinize, wash the cancer cells 1x using PBS (5 mL per 75 cm² flask) followed by incubation in an HBSS solution containing 0.05% trypsin and 0.53 mM EDTA (2 mL per 75 cm² flask).
2. Transfer the cell suspension into a 15 mL conical tube and centrifuge at 800 x g for 5 min at room temperature (RT).
3. Remove and discard the supernatant.
4. Resuspend the pellet in 2 mL of DMEM containing 2% fetal bovine serum (FBS) and 1% antibiotic/antimycotic. Count live cells.
5. Assign hemi-calvarias to each study group (i.e., the negative control and coculture group for RNA or histology analysis).
6. Remove the culture media from the hemi-calvarias and add 1 mL of DMEM containing 2% FBS and 1% antibiotic/antimycotic supplemented or not supplemented with cancer cells.
   NOTE: The amount of cells to add can change depending on the cell line tested. With cancer cells like MDA-MB-231 or PC-3, 500,000 cells per well work appropriately.
7. Incubate for 24 h at 37 °C with 5% CO₂. Pass each hemi-calvaria to a new well to retain only cancer cells that adhered to the bone tissue.
8. Incubate for 7 days at 37 °C with 5% CO₂ and change the media every 2-3 days.

4. Fixation

1. Cut squares of tissue paper to wrap the hemi-calvarias.
   NOTE: Biopsy foam pads or steel capsules for small biopsies can also be used.
2. Use straight fine-tip forceps to pick up each hemi-calvaria from the sagittal suture, place on a tissue paper, and wrap.
3. Place the wrapped hemi-calvaria inside a labeled embedding cassette.
4. Place the cassette into a container with 10% phosphate-buffered formalin.
5. Fix for 24 h at 4 °C.

5. Decalcification

1. Remove the formalin, add 1x PBS, and agitate the tissues for 30 min to rinse the hemi-calvarias.
2. Remove the PBS and add 10% EDTA (pH = 8, 0.34 M).
   NOTE: Verify that the solution covers the tissues completely.
3. Decalcify the tissues for 48 h at 4 °C.
4. Discard the EDTA solution and add 1x PBS to rinse the tissue.
5. Store the hemi-calvarias in 70% ethanol until the histology processing.

6. Tissue processing

1. Dehydrate the tissues with rounds of 96% ethanol, 60 min (3x), followed by 100% ethanol, 60 min (3x).
2. Replace the ethanol by 100% xylene, 60 min (3x).
3. Incubate the cassettes in paraffin wax, 60 min (2x).

7. Embedding

1. Open the cassettes, carefully remove the tissue paper, and unwrap the calvaria.
2. Pick up each calvaria carefully and stack all the hemi-calvarias from the same group in the same orientation.
3. Put some paraffin in a mold.
4. Pick up all hemi-calvarias with the forceps and place them inside the mold with the sagittal suture down towards the base of the mold.
   NOTE: Orientation of the hemi-calvarias in the mold during inclusion is crucial to obtain consistent histological sections and reproducible results because this orientation will allow posterior identification of the front and parietal bones from the calvarias and the coronal suture facilitating the quantitative assessment.
5. Release the forceps and verify that the hemi-calvarias stay in place.
6. Place the labeled cassette on top of the mold and fill it with more paraffin to cover the hemi-calvarias.
7. Move the molds to the cold surface.

8. Sectioning

1. Trim 500-600 µm of the sagittal suture with the microtome.
2. Cut 4 µm thick sections, and collect the sections needed.
3. Trim another 300 µm.
4. Cut and collect another six 4 µm thick sections.
5. Trim the block 300 µm further and collect more sections.
6. Mount the sections onto glass microscope slides.
7. Dry the slides at RT.

9. Staining

1. Immerse the sections in 100% xylene for 3 min.
2. Submerge in 100% ethanol for 1 min.
3. Merge in 96% ethanol for 1 min.
4. Immerse in 80% ethanol for 1 min.
5. Submerge in 70% ethanol for 1 min.
6. Rinse in water for 3 min.
7. Submerge in hematoxylin for 3 min.
8. Rinse in water until the section is clear.
9. Submerge in a saturated lithium carbonate solution for 10 sec.
10. Rinse in water for 3 min.
11. Submerge in 96% ethanol for 1 min.
12. Submerge in eosin for 3 min.
13. Immerse in 96% ethanol for 1 min.
14. Submerge in 100% ethanol for 1 min.
15. Submerge in 100% xylene for 3 min.
16. Add some per mount-mounting medium to the slide and protect it with a coverslip.
    NOTE: You can complement the hematoxyline and eosin (H&E) staining with tartrate-resistant acid phosphatase (TRAP) staining to evaluate osteoclast and osteolysis.

10. Quantitative assessment: defining area for analysis

1. Examine the sections under low power (i.e., 4x) to identify the orientation and the sutures.
2. Define the coronal suture and identify the long bone surface on one side and the short surface on the other.
3. Identify the coronal suture under 40x magnification, and move two or three optical fields away from the suture along the long surface. Capture images of this area for analysis.
4. Define the old bone area and the new bone area. The eosin Y with orange G stains the old bone darker and the new bone lighter.
5. Measure the total bone area of the old and new bone with Image J software using the color threshold tool. Express the results as µm².

11. Data analysis

1. Analyze the results using statistical software. Significant differences between groups can be determined using appropriate tests (e.g., nonparametric Mann-Whitney U test as is done herel).

Results

To evaluate bone formation in the calvarial model, we cultivated the hemi-calvarias in media with or without 50 µg/mL of insulin. Tissue sections were prepared and stained with H&E. In these conditions, the histology showed that the structural integrity of the calvarial bone was maintained, allowing the identification of its different components (Figure 1). The calvarias treated with insulin presented an increase in the amount of bone tissue compared to t...

Discussion

Here, we describe the protocol for a calvarial ex vivo model to evaluate bone formation or resorption and to study the interactions of cancer cells with calvarial mouse bone. The critical steps of this technique are the dissection, culture, embedding, and histomorphometrical analysis of the calvarias. During the dissection of the calvarias, it is crucial to cut the hemi-calvarias into a trapezoid, as it will strongly facilitate the orientation during the paraffin inclusion. When studying cancer cell interactions...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
24 well cell culture	Corning	CLS3524
24 well non tissue culture	Falcon	15705-060
2 mL cryovial	SSI	2341-S0S
Antibiotics-Antimycotic	Corning	30-004-CI
BSA	Biowest	P6154-100GR
Centrifugue	Eppendorf	22628188	Centrifuge 5810R
Coverslips	Corning	2935-24X50
Cytoseal resin	Richard Allen	8310-10
DMSO		D2650-100ML
Dulbecco's Modification of Eagles Medium, with 4.5 g/L glucose and L-glutamine, without sodium pyruvate	Corning	10-017-CV
Dulbecco's PBS (10X)	Corning	20-031-CV
Ebedding Cassettes	Sigma	Z672122-500EA
EDTA	Golden	26400
Embedding Workstation	Thermo Scientific	A81000001
Eosin	Golden	60600
Ethanol absolute	JALMEK	E5325-17P
Fetal Bovine Serum	Biowest	BIO-S1650-500
Filters	Corning	CLS431229
Forceps and scissors	LANCETA HG	74165
Formalin buffered 10%	Sigma	HT501320
Glass slides 25 x 75 mm	Premiere	9105
Harris's Hematoxylin	Jalmek	SH025-13
High profile blades	Thermo Scientific	1001259
Histoquinet	Thermo Scientific	813150	STP 120
Insulin from bovine pancreas	Sigma	16634
Microscope	ZEISS	Axio Scope.A1
Microtome	Thermo Scientific	905200	MICROM HM 355S
Mouse food, 18% prot, 2018S	Harlan	T.2018S.15
Neubauer	VWR	631-0696
Orange G	Biobasic	OB0674-25G
Paraffin	Paraplast	39601006
Paraffin Section Flotation Bath	Electrothermal	MH8517X1
Petri dish	Corning	CLS430167
Phloxin B	Probiotek	166-02072
Trypan Blue	Sigma	T8154
Trypsin-EDTA	Corning	25-051-CI
Wax dispenser	Electrothermal	MH8523BX1
Xylene	Golden	534056-500ML